VERGE GENOMICS

Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.

#SimilarOrganizations #People #Financial #Event #Website #More

VERGE GENOMICS

Social Links:

Industry:

Biotechnology Genetics Health Care Machine Learning Neuroscience

Founded:

2015-01-01

Address:

San Francisco, California, United States

Country:

United States

Website Url:

http://www.vergegenomics.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

134.12 M USD

Technology used in webpage:

Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Google Apps For Business

Similar Organizations

clear-gene-logo

Clear Gene

Clear Gene improving diagnostics, from cancer to Covid.

cofactor-genomics-logo

Cofactor Genomics

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

editas-medicine-logo

Editas Medicine

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

engine-biosciences-logo

Engine Biosciences

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

helixnano-logo

HelixNano

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

occamzrazor-logo

OccamzRazor

OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.

postera-logo

PostEra

PostEra is a biotech company using its advances in machine learning for medicinal chemistry to get more cures to patients

Current Advisors List

mario-saltarelli_image

Mario Saltarelli Scientific Advisory Board @ Verge Genomics
Board_member
2021-05-01

naveen-jain_image

Naveen Jain Investor @ Verge Genomics
Advisor
2018-06-01

Current Employees Featured

alice-zhang_image

Alice Zhang
Alice Zhang Co-Founder & CEO @ Verge Genomics
Co-Founder & CEO
2015-07-01

victor-hanson-smith_image

Victor Hanson-Smith
Victor Hanson-Smith Head of Computational Biology @ Verge Genomics
Head of Computational Biology
2017-02-01

jason-chen_image

Jason Chen
Jason Chen Co-founder @ Verge Genomics
Co-founder
2014-11-01

irene-choi_image

Irene Choi
Irene Choi Director, Drug Discovery @ Verge Genomics
Director, Drug Discovery
2017-03-01

jane-rhodes_image

Jane Rhodes
Jane Rhodes Chief Business Officer @ Verge Genomics
Chief Business Officer

robert-galemmo_image

Robert Galemmo
Robert Galemmo Head of Medicinal Chemistry @ Verge Genomics
Head of Medicinal Chemistry
2021-04-01

Founder

alice-zhang_image

Alice Zhang

jason-chen_image

Jason Chen

Investors List

eli-lilly_image

Eli Lilly

Eli Lilly investment in Series B - Verge Genomics

lifeforce-capital_image

Lifeforce Capital

Lifeforce Capital investment in Series B - Verge Genomics

tao-capital-partners_image

Tao Capital Partners

Tao Capital Partners investment in Series B - Verge Genomics

vulcan-capital_image

Vulcan Capital

Vulcan Capital investment in Series B - Verge Genomics

threshold_image

Threshold

Threshold investment in Series B - Verge Genomics

als-investment-fund_image

ALS Investment Fund

ALS Investment Fund investment in Series B - Verge Genomics

blackrock_image

BlackRock

BlackRock investment in Series B - Verge Genomics

alumni-ventures-group_image

Alumni Ventures

Alumni Ventures investment in Series B - Verge Genomics

section-32_image

Section 32

Section 32 investment in Series B - Verge Genomics

merck-global-health-innovation-fund_image

Merck Global Health Innovation Fund

Merck Global Health Innovation Fund investment in Series B - Verge Genomics

Newest Events participated

Participated in Y Combinator Summer 2015 Demo Day on 2015-08-18 as exhibitor

Key Employee Changes

Date	New article
2021-05-05	Verge Genomics Names Robert Scannevin, Ph.D., Chief Scientific Officer

Official Site Inspections

http://www.vergegenomics.com Semrush global rank: 2.85 M Semrush visits lastest month: 5.68 K

Host Informations
Whois Informations

Loading ...

More informations about "Verge Genomics" on Search Engine